Legend Biotech develops and sells cell therapies for cancer, led by CARVYKTI for multiple myeloma. It last closed at $16.11 on Nov 17, up 0.75% on the day. LEGN last reported earnings on Tue, Nov 10, 2026. The average 12-month price target from 6 analysts is $38.67 (+140.0% from the last close), with a high of $61.00 and a low of $20.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in LEGN, 0% of them bullish and 100% bearish. In the past 30 days there were 4 dark pool prints totaling $8.3M, the largest $6.2M.
From LEGN's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 10). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.
Each firm's latest rating on LEGN in the past 90 days
Average 12-month target
$38.67
▲ 140.0% upside
Based on 6 analysts who set a price target on LEGN in the past 90 days. The average target is $38.67, with a high of $61.00 and a low of $20.00, compared with the last close of $16.11.
Low $20.00Avg $38.67High $61.00
Blue marker: last close $16.11
Highest target$61.00
Average target$38.67
Lowest target$20.00
Latest rating changes
Evercore ISI GroupDowngrade
Nov 16Hold$20
OppenheimerMaintained
Nov 11Buy$25
Morgan StanleyMaintained
Nov 11Buy$43
BarclaysTarget lowered
Nov 11Buy$68 → $61
RBC CapitalTarget lowered
Nov 11Buy$56 → $50
Date
Firm
Action
Rating
Price target
Nov 16
Evercore ISI Group
Downgrade
Hold
$20
Nov 11
Oppenheimer
Maintained
Buy
$25
Nov 11
Morgan Stanley
Maintained
Buy
$43
Nov 11
Barclays
Target lowered
Buy
$68 → $61
Nov 11
RBC Capital
Target lowered
Buy
$56 → $50
Loading…
Technical Analysis
LEGN · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 27% below its 20 day and 20% below its 50 day average. It is 38% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 34), oversold. The nearest support is the 52 week low at $15.75, and the nearest resistance the Pivot at $16.12.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 8.8%/day
Key levels
$37.5052 week high+132.8%
$22.18200 day average+37.7%
$20.95100 day average+30.0%
$20.4420 day average+26.9%
$19.92Swing high (Oct 15)+23.6%
$19.3750 day average+20.2%
$16.49Pivot R1+2.4%
$16.12Pivot+0.1%
$16.11Last close
$15.7552 week low−2.2%
$15.74Pivot S1−2.3%
Indicators
RSI (14)
33.83
Weak, oversold below 30
Neutral
MACD
-0.57
Below its signal line
Bearish
Stochastic
2.0
Near the bottom of its range
Oversold
ADX (14)
23.5
Weak trend
Williams %R
-95.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-153.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.0%
Change over 10 sessions
Bearish
ATR (14)
$1.41
Typical daily range, 8.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityHigh, 19.6%/day
Key levels
$37.5052 week high+132.8%
$22.18200 day average+37.7%
$20.95100 day average+30.0%
$20.4420 day average+26.9%
$19.92Swing high (Oct 15)+23.6%
$19.3750 day average+20.2%
$16.49Pivot R1+2.4%
$16.12Pivot+0.1%
$16.11Last close
$15.7552 week low−2.2%
$15.74Pivot S1−2.3%
Indicators
RSI (14)
39.96
Weak, oversold below 30
Neutral
MACD
-1.49
Below its signal line
Bearish
Stochastic
34.8
Middle of its range
Neutral
ADX (14)
14.3
No clear trend
Williams %R
-95.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-146.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−13.6%
Change over 10 sessions
Bearish
ATR (14)
$3.16
Typical daily range, 19.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for LEGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LEGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow LEGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LEGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LEGN is in one of them and how their past LEGN trades turned out.
Legend Biotech is a biopharmaceutical company in Somerset, New Jersey, that discovers, develops, manufactures and commercializes cell therapies for cancer. Its main product, CARVYKTI, treats multiple myeloma, a blood cancer, and is made from each patient's own immune cells. The company develops this therapy with Janssen and has other cancer cell therapies in early development, including for lung, gastric and pancreatic cancer.